John Larsen, PA
Physician Assistant · Reno, NVNPI 1538422118
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Regeneron Healthcare Solutions, Inc. accounts for 63.3% of it on its own, with 40 other manufacturers making up the rest. 2025 is the largest year on record at $37,581, more than ten times the $2,000 reported in 2021. Among physician assistant clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 561 payments — averaging $87.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$31K
- AstraZeneca$5K
- Sanofi$4K
- GSK$3K
- Regeneron$1K
- AbbVie$597
- plus $4K from 35 others
What the payments were for
- Consulting fees$11,98324%
- Speaking & faculty fees$18,39837%
- Travel & lodging$6,15212%
- Food & beverage$12,68426%
- Education$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 130 | $31,214 |
| AstraZeneca(2 entities) | 74 | $5,413 |
| Sanofi | 17 | $3,714 |
| GSK | 116 | $3,051 |
| Regeneron | 2 | $1,344 |
| AbbVie | 40 | $597 |
| Bayer | 2 | $400 |
| Mylan Specialty L.p. | 9 | $311 |
| Grifols USA, LLC | 5 | $288 |
| Baxter Healthcare | 14 | $264 |
| Boehringer Ingelheim | 13 | $244 |
| Biohaven Pharmaceutical Holding Company Ltd. | 29 | $239 |
| Actelion Pharmaceuticals US, Inc. | 3 | $215 |
| Verona Pharma, Inc. | 5 | $209 |
| Biogen | 10 | $181 |
| Biohaven Pharmaceuticals, Inc. | 20 | $155 |
| EMD Serono, Inc. | 6 | $155 |
| Neurocrine Biosciences, Inc. | 6 | $147 |
| Lilly USA, LLC | 2 | $136 |
| Advanced Respiratory, Inc | 14 | $133 |
| Bristol Myers Squibb | 7 | $131 |
| Amgen | 7 | $125 |
| Lundbeck LLC | 5 | $88 |
| Mannkind Corporation | 1 | $78 |
| Pfizer | 4 | $67 |
| Merck | 2 | $43 |
| Acorda Therapeutics, Inc | 2 | $39 |
| Johnson & Johnson | 2 | $38 |
| Upsher-smith Laboratories LLC | 2 | $36 |
| Argenx US, Inc. | 1 | $32 |
| Cala Health, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $25 |
| Exact Sciences | 1 | $22 |
| Insmed, Inc. | 1 | $20 |
| Viatris Specialty LLC | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Banner Life Sciences, LLC | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| UCB, Inc. | 1 | $17 |
| Novartis | 1 | $16 |
| Impel Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$33,457
- BREZTRI$1,373
- FASENRA$1,367
- AIRSUPRA$681
- Adempas$400
- NUCALA$364
- AREXVY$240
- Prolastin-C Liquid$233
- FARXIGA$217
- Hillrom - Life 2000 Ventilation System$117
- TRELEGY ELLIPTA$115
- ZEPBOUND$115
- UPTRAVI$113
- OPSUMIT$113
- TEZSPIRE$113
How this compares
$49,302 in reported general payments places this provider in the 95th percentile of 881 physician assistant providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 828 | $612,952 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 285 | $215,168 |
| Dupixent PenDupilumab | 48 | $178,024 |
| NucalaMepolizumab | 45 | $161,828 |
| XolairOmalizumab | 26 | $82,950 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 79 | $54,285 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 50 | $29,672 |
| Spiriva RespimatTiotropium Bromide | 35 | $27,031 |
| Breo ElliptaFluticasone/Vilanterol | 52 | $22,909 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 37 | $20,846 |
| AirsupraAlbuterol Sulfate/Budesonide | 19 | $11,612 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 179 | $6,611 |
| Arnuity ElliptaFluticasone Furoate | 17 | $3,809 |
| Montelukast Sodium | 247 | $3,290 |
| Advair DiskusFluticasone Propion/Salmeterol | 12 | $2,992 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Nucala, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta | $3,051 | $822,344979 claims |
| AstraZenecaBreztri Aerosphere, Airsupra | $5,413 | $226,780304 claims |
| Boehringer IngelheimCombivent Respimat, Stiolto Respimat, Spiriva Respimat | $244 | $110,989164 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 881 physician assistant providers in Nevada.
Other physician assistant in Reno
- Laura BiehleReno$36K
- Benjamin ProhaskaReno$31K
- Rebecca SparksReno$16K
- Daniel CollReno$12K
- Cameron WheelerReno$11K
- Julia WronaReno$10K
- Amber FrancoReno$9K
- Paul JohnsReno$8K
- Shannon WeaverReno$7K
- Leila NazparvarReno$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.